Abstract:The 2‐nitroimidazole based 99mTc‐radiopharmaceuticals are widely explored for imaging tumor hypoxia. Radiopharmaceuticals for targeting hypoxia are often lipophilic and therefore, show significant uptake in liver and other vital organs. In this context, lipophilic radiopharmaceuticals with design features enabling faster clearance from liver may be more desirable. A dipicolylamine‐NCS bifunctional chelator that could generate a thiourea‐bridge up on conjugation to primary amine bearing molecule was used to synthesize a 2‐nitroimidazole‐dipicolyl amine ligand for radiolabeling with 99mTc(CO)3 core. Corresponding Re(CO)3‐analogue was prepared to establish the structure of 2‐nitroimidazole‐99mTc(CO)3 complex prepared in trace level. The 2‐nitroimidazole‐99mTc(CO)3 complex showed a hypoxic to normoxic ratio of ~2.5 in CHO cells at 3 h. In vivo, the complex showed accumulation and retention in tumor with high tumor to blood and tumor to muscle ratio. The study demonstrated the utility of metabolizable thiourea‐bridge in 2‐nitroimidazole‐99mTc(CO)3 complex in inducing faster clearance of the radiotracer from liver. The dipicolylamine‐NCS bifunctional chelator reported herein can also be used for radiolabeling other class of target specific molecules with 99mTc(CO)3 core.

Facile synthesis of bis(hydroxamamide)-based tetradentate ligands for 99mTc-radiopharmaceutical.

Facile synthesis of bis(hydroxamamide)-based tetradentate ligands for Tc-radiopharmaceutical

Synthesis of Magnetic Resonance Imaging Contrast Agent with Tethered Quaternary Ammonium Group

Radiosynthesis of Tritium-Labeled Novel Nitromethylene Neonicotinoids Compounds with NaB3H4

Synthesis, Biodistribution and Quantitative Structure-Activity Relationship Studies of New 99mtc Labeled Pseudo-Peptide Complexes.

Synthesis and in Vitro Evaluation of Three (99M)tc-Labeled Hydroxamamide-Based Ligands As Markers for Hypoxic Cells

Synthesis of 99mTc-aroylhydrazinocarbonylmethyliminodiacetic acids and their animal study, hepatobiliary pharmaceuticals

Synthesis and Biodistribution of the 99m Tc Nitrido Complex with 2-(4-nitro-1h-imidazolyl)ethyl Dithiocarbamate (NIET)

Preparation of New Technetium-99m Nns/X Complexes and Selection for Brain Imaging Agent

Synthesis, Characterization and Biodistribution of New 99m Tc Nitrido Complexes with Derivatives of Alkyl Xanthates

Synthesis and Preliminary Biological Evaluation of a Technetium-99M Labeled Thymidine Analog

Synthesis And Biodistribution Of Novel Tc-99m Labeled 4-Nitroimidazole Dithiocarbamate Complexes As Potential Agents To Target Tumor Hypoxia

A thiourea‐bridged 99mTc(CO)3‐dipicolylamine‐2‐nitroimidazole complex for targeting tumor hypoxia: Utilizing metabolizable thiourea‐bridge to improve pharmacokinetics

Nitriles Form Mixed-Coligand Complexes with 99Mtc-Hynic-peptide

Synthesis and Properties of Neutral Gadolinium and Technetium-99M-labeled Complexes

[Tc-99M(co)(3)](+) Labeled Histidine Derivative Containing 4-Nitroimidazole: Synthesis, Biodistribution As A Tumor Hypoxia Imaging Agent

PREPARATION AND BIODISTRIBUTION OF 99Tcm-AIPO

Development of 99tcm Labelled Mixed-ligand Complexes

Synthesis and Biological Evaluation of Novel 99Mtcn-Labeled Bisnitroimidazole Complexes Containing Monoamine-Monoamide Dithiol As Potential Tumor Hypoxia Markers

Synthesis and Biodistribution of 99Mtc-Peptides Conjugated Adenine As Tumor Imaging Agents

Facile Synthesis of 1-(Acetic Acid)-4,7,10-Tris(Tert-Butoxycarbonylmethyl)-1,4,7,10-Tetraazacyclododec Ane: A Reactive Precursor Chelating Agent